Thomas Unger

Active 1979–2024

134
Papers
25,682
Citations
92
h-index
131
i10-index

Citations

Citations per year for Thomas Unger1980: 2 citations1981: 1 citations1982: 2 citations1983: 4 citations1984: 3 citations1985: 8 citations1986: 10 citations1987: 13 citations1988: 24 citations1989: 13 citations1990: 31 citations1991: 22 citations1992: 36 citations1993: 37 citations1994: 36 citations1995: 41 citations1996: 58 citations1997: 78 citations1998: 82 citations1999: 130 citations2000: 86 citations2001: 103 citations2002: 75 citations2003: 108 citations2004: 118 citations2005: 143 citations2006: 147 citations2007: 152 citations2008: 183 citations2009: 220 citations2010: 209 citations2011: 191 citations2012: 231 citations2013: 185 citations2014: 182 citations2015: 171 citations2016: 124 citations2017: 150 citations2018: 92 citations2019: 373 citations2020: 457 citations2021: 456 citations2022: 327 citations2023: 258 citations2024: 354 citations2025: 158 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,733 citing papers, 24% of this breakdownChina: 589 citing papers, 8.1% of this breakdownGermany: 550 citing papers, 7.6% of this breakdownUnited Kingdom: 377 citing papers, 5.2% of this breakdownCanada: 310 citing papers, 4.3% of this breakdownAustralia: 304 citing papers, 4.2% of this breakdownFrance: 299 citing papers, 4.1% of this breakdownJapan: 272 citing papers, 3.8% of this breakdownItaly: 260 citing papers, 3.6% of this breakdownSpain: 196 citing papers, 2.7% of this breakdownNetherlands: 194 citing papers, 2.7% of this breakdownBrazil: 154 citing papers, 2.1% of this breakdown
0%24%Other 27.6%

Fields

  • Medicine67.5%
  • Biochemistry, Genetics and Molecular Biology12.6%
  • Neuroscience7.1%
  • Engineering3.1%
  • Psychology2%
  • Immunology and Microbiology1.9%
  • Other5.8%

Topics

  • Renin-Angiotensin System Studies8%
  • Hormonal Regulation and Hypertension4.4%
  • Blood Pressure and Hypertension Studies3.7%
  • Receptor Mechanisms and Signaling3.3%
  • Adipokines, Inflammation, and Metabolic Diseases2.6%
  • Neuroscience of respiration and sleep2.4%
  • Other75.6%

Coauthors

All papers

Open in search
  1. 2020 International Society of Hypertension Global Hypertension Practice Guidelines

    Authors: , , , , , , , , , , , , - Hypertension 2020 cited by 4,097

  2. Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , U. Muscha Steckelings, George S. Stergiou, Rhian M. Touyz, Thomas Unger, Richard D. Wainford, Ji‐Guang Wang, Bryan Williams, Brandi M. Wynne, Maciej Tomaszewski - Cardiovascular Research 2022 cited by 138

  3. T-lymphocyte Infiltration in Visceral Adipose Tissue

    Authors: , , , , , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2008 cited by 678

  4. Pharmacological depletion of microglia and perivascular macrophages prevents vascular Cognitive Impairment in Ang II-induced Hypertension

    Authors: , , , , , , , , , , , , - Theranostics 2020 cited by 72

  5. Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula

    Authors: , , , , - Journal of Molecular Medicine 2006 cited by 858

  6. May Measurement Month 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of MMM Investigators* - Hypertension 2020 cited by 259

  7. The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

    Authors: , , , , , , , , , - Pharmacological Reviews 2022 cited by 83

  8. Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 855

  9. Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ

    Authors: , , , , , , , , , , , , - PLoS Genetics 2008 cited by 285

  10. Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function

    Authors: , - Blood Pressure 2003 cited by 455

  11. Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic Cardiomyopathy

    Authors: , , , , , , , , , - Diabetes 2007 cited by 268

  12. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea

    Authors: , , , , , - Journal of Applied Physiology 1992 cited by 430

  13. Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS

    Authors: , , , , , , , , , , , , , , , , , , , - Hypertension 2017 cited by 107

  14. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection

    Authors: , , , , , , , - Clinical Research in Cardiology 2008 cited by 164

  15. Passenger and heavy vehicle collisions with pedestrians: Assessment of injury mechanisms and risk

    Authors: , , , , , , - Accident Analysis & Prevention 2023 cited by 24

  16. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

    Authors: , , , , , , , , , , , , , , , - The Lancet Neurology 2010 cited by 211

  17. Algebraic Structures for Capturing the Provenance of SPARQL Queries

    Authors: , , , , - Journal of the ACM, J. ACM 2016 cited by 28

  18. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.

    Authors: , , , , - Hypertension 1992 cited by 495

  19. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

    Authors: , , , , , , , , , , , , , , - Journal of Hypertension 2008 cited by 230

  20. Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk

    Authors: , , , , , , , - Circulation 2012 cited by 118

  21. Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome

    Authors: , , , , , , , , , , , , - Journal of Molecular Medicine 2013 cited by 96

  22. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

    Authors: , , , , , - Journal of Clinical Investigation 1995 cited by 912

  23. Hypertension caused by chronic intermittent hypoxia – influence of chemoreceptors and sympathetic nervous system

    Authors: , , , - Journal of Hypertension 1997 cited by 299

  24. Angiotensin II and the fibroproliferative response to acute lung injury

    Authors: , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2004 cited by 274